Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Cao, A Yong ^a,b   Huang, Liang ^a,b   Wu, Jiong ^a,b   Lu, Jin Song ^a,b   Liu, Guang Yu ^a,b   Shen, Zhen Zhou ^a,b   Shao, Zhi Ming ^a,b   Di, Gen Hong ^a,b  

^a Breast Cancer Institute   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Clinical outcome; Invasive lobular carcinoma; Tumor characteristics

Indexed keywords

ANTHRACYCLINE; METHOTREXATE; TAXANE DERIVATIVE;

ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CENTRAL NERVOUS SYSTEM METASTASIS; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; GASTROINTESTINAL TRACT METASTASIS; HUMAN; INTRADUCTAL CARCINOMA; LIVER METASTASIS; LONG TERM CARE; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; OVARY METASTASIS; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATHOPHYSIOLOGY; PHENOTYPE; PLEURA METASTASIS; RECURRENCE FREE SURVIVAL; RISK FACTOR; SKIN METASTASIS; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 84869475114     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-152     Document Type: Article

References (25)

1. Borst MJ, Ingold JA. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 1993, 114:637-641.
2. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996, 77:113-120. 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8, 8630916.
3. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004, 6:R149-R156. 10.1186/bcr767, 400666, 15084238.
4. Biglia N, Mariani L, Sgro L, Mininanni P, Moggio G, Sismondi P. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment. Endocr Relat Cancer 2007, 14:549-567. 10.1677/ERC-06-0060, 17914088.
5. Cocquyt V, Van Belle S. Lobular carcinoma in situ and invasive lobular cancer of the breast. Curr Opin Obstet Gynecol 2005, 17:55-60.
6. Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, Boraas M, Sigurdson ER, Hoffman JP, Eisenberg BL, Patchefsky A. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 2001, 91:1862-1869. 10.1002/1097-0142(20010515)91:10<1862::AID-CNCR1207>3.0.CO;2-#, 11346867.
7. Quan ML, Sclafani L, Heerdt AS, Fey JV, Morris EA, Borgen PI. Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncol 2003, 10:1048-1053. 10.1245/ASO.2003.03.016, 14597443.
8. Franceschini G, Manno A, Mulè A, Verbo A, Rizzo G, Sermoneta D, Petito L, D'alba P, Maggiore C, Terribile D, Masetti R, Coco C. Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: report of a case and review of the literature. BMC Cancer 2006, 6:193. 10.1186/1471-2407-6-193, 1550421, 16854225.
9. Yu J, Dabbs DJ, Shuai Y, Niemeier LA, Bhargava R. Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics. Am J Clin Pathol 2011, 136:88-97. 10.1309/AJCP7URIW0QETTAT, 21685036.
10. Fortunato L, Mascaro A, Poccia I, Andrich R, Amini M, Costarelli L, Cortese G, Farina M, Vitelli C. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? Analysis of an institutional database over a 10-year period. Ann Surg Oncol 2012, 19:1107-1114. 10.1245/s10434-011-1907-9, 21913022.
11. Jayasinghe UW, Bilous AM, Boyages J. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?. Breast J 2007, 13:479-485. 10.1111/j.1524-4741.2007.00468.x, 17760669.
12. Toikkanen S, Pylkkänen L, Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 1997, 76:1234-1240. 10.1038/bjc.1997.540, 2228126, 9365176.
13. Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Richardson AL, Schnitt SJ, Schmitt FC, Tan PH, Tse GM, Badve S, Ellis IO. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 2010, 12:207. 2949637, 20804570.
14. Muñoz M, Fernández-Aceñero MJ, Martín S, Schneider J. Prognostic significance of molecular classification of breast invasive ductal carcinoma. Arch Gynecol Obstet 2009, 280:43-48. 10.1007/s00404-008-0867-1, 19082617.
15. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010, 12:R68. 10.1186/bcr2635, 3096954, 20813035.
16. Hussien M, Lioe TF, Finnegan J, Spence RA. Surgical treatment for invasive lobular carcinoma of the breast. Breast 2003, 12:23-35. 10.1016/S0960-9776(02)00182-0, 14659352.
17. Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol 1997, 4:545-550. 10.1007/BF02305534, 9367019.
18. Raje D, Bollard R, Wilson A. Invasive lobular cancer of the breast-is breast conservation surgery a good option?. Breast J 2006, 12:574-575. 10.1111/j.1524-4741.2006.00351.x, 17238992.
19. Yeatman TJ, Cantor AB, Smith TJ, Smith SK, Reintgen DS, Miller MS, Ku NN, Baekey PA, Cox CE. Tumor biology of infiltrating lobular carcinoma.Implications for management. Ann Surg 1995, 222:549-559. 1234890, 7574934.
20. Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg 2005, 242:281-289. 10.1097/01.sla.0000171306.74366.22, 1357735, 16041220.
21. Papaioannou N, Zervoudis S, Grammatikakis I, Peitsidis P, Palvakis K, Youssef TF. Metastatic lobular carcinoma of the breast to the vulva: a case report and review of the literature. J Egypt Natl Canc Inst 2010, 22:57-60.
22. Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, Holmberg SB, Lindtner J, Snyder R, Thürlimann B, Murray E, Viale G, Castiglione-Gertsch M, Coates AS, Goldhirsch A. International Breast Cancer Study Group: Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol 2008, 26:3006-3014. 10.1200/JCO.2007.14.9336, 18458044.
23. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005, 93:1046-1052. 10.1038/sj.bjc.6602787, 2361680, 16175185.
24. Adams AL, Li Y, Pfeifer JD, Hameed O. Nuclear grade and survival in invasive lobular carcinoma: a case series with long-term follow-up. Breast J 2010, 16:445-447.
25. Bane AL, Tjan S, Parkes RK, Andrulis I, O'Malley FP. Invasive lobular carcinoma: to grade or not to grade. Mod Pathol 2005, 18:621-628. 10.1038/modpathol.3800273, 15605082.